First Registry Annual Report on the Use of Biologics for Inflammatory Bowel Diseases 

The IBD Registry has published its first Annual-Report-on-the-Use-of-Biologics-for-Inflammatory-Bowel-Diseases-2018-19-IBD-Registry-Oct-2019  for the year 2018-19. (1.8MB)

The report includes the cumulative results to January 2019 from April 2016 when the Registry assumed the role of supporting the National Audit of Biological Therapies from the Royal College of Physicians.

The focus is on progress during the calendar year 2018 with comparative data from 74 IBD clinical teams in England & Wales participating in our rolling audit.

The report also refers to the larger clinical dataset captured by the IBD Registry which aims to provide a longitudinal picture of the care received by people with IBD.

IBD Registry Medical Director Dr Stuart Bloom said, “We hope the results and commentary prove of interest to clinicians and others involved in managing IBD, as well as to the 500,000 people living with these diseases in the UK.” 

Thank you to all participating IBD teams for their huge efforts in making this report a reality. If you have any questions or feedback, we would be keen to hear.

Contact us at support@ibdregistry.org.uk for more information.

Find out more about:

 

Latest News

Abbreviated clinician news for IBD Teams – March 2020

Given the special circumstances putting pressure on IBD teams and wider health services, we have created some in-depth articles below in an easy to read format:  Switchers: Changing originator biologic to biosimilar Changing originator biologic to biosimilar With many...

read more

Registry surpasses 60,000 patient records

Huge congratulations to IBD clinical teams across the country - we have surpassed the 60,000 patient record mark. At time of writing we hold 63,181 records. 62 IBD teams submitted for this last quarter, 24% more than the same period last year. Figure: number of...

read more
%d bloggers like this: